Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study

Introduction: Interleukin 6 receptor inhibition by tocilizumab (TCZ) has been effectively used worldwide for the treatment of multisystem inflammatory syndrome (MIS) associated with COVID-19. In this single centre study, we compared the outcome of COVID-19 pneumonia in TCZ-treated vs. untreated (con...

Descripción completa

Detalles Bibliográficos
Autores principales: Kardos, Zsófia, Szabó, Miklós, Baráth, Zsuzsanna, Miksi, Ágnes, Oláh, Csaba, Kozma, Ádám, Gergely, József A., Csánky, Eszter, Szekanecz, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953028/
https://www.ncbi.nlm.nih.gov/pubmed/36830885
http://dx.doi.org/10.3390/biomedicines11020349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953028/
https://www.ncbi.nlm.nih.gov/pubmed/36830885
http://dx.doi.org/10.3390/biomedicines11020349

Ejemplares similares